Eurofins Scientific SE (ESF0) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Eurofins Scientific SE (ESF0) has a cash flow conversion efficiency ratio of 0.069x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€334.05 Million ≈ $390.54 Million USD) by net assets (€4.85 Billion ≈ $5.67 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Eurofins Scientific SE defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Eurofins Scientific SE - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Eurofins Scientific SE's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Eurofins Scientific SE Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Eurofins Scientific SE ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dayforce Inc.
NYSE:DAY
|
0.012x |
|
Allegion PLC
NYSE:ALLE
|
0.048x |
|
Axsome Therapeutics Inc
NASDAQ:AXSM
|
-0.379x |
|
Vicor Corporation
NASDAQ:VICR
|
-0.005x |
|
Joint Stock Commercial Bank for Investment and Development of Vietnam
VN:BID
|
0.467x |
|
JAMES HARDIE INDUST.ADR/1
F:JHA0
|
N/A |
|
Hecla Mining Company
NYSE:HL
|
0.084x |
|
Lupin Limited
NSE:LUPIN
|
0.147x |
Annual Cash Flow Conversion Efficiency for Eurofins Scientific SE (2016–2025)
The table below shows the annual cash flow conversion efficiency of Eurofins Scientific SE from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see ESF0 market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €4.58 Billion ≈ $5.35 Billion |
€1.40 Billion ≈ $1.64 Billion |
0.306x | +24.79% |
| 2024-12-31 | €5.38 Billion ≈ $6.30 Billion |
€1.32 Billion ≈ $1.54 Billion |
0.245x | +23.62% |
| 2023-12-31 | €5.14 Billion ≈ $6.01 Billion |
€1.02 Billion ≈ $1.19 Billion |
0.198x | -15.41% |
| 2022-12-31 | €4.85 Billion ≈ $5.67 Billion |
€1.14 Billion ≈ $1.33 Billion |
0.234x | -27.51% |
| 2021-12-31 | €4.68 Billion ≈ $5.47 Billion |
€1.51 Billion ≈ $1.77 Billion |
0.323x | -1.84% |
| 2020-12-31 | €3.72 Billion ≈ $4.34 Billion |
€1.22 Billion ≈ $1.43 Billion |
0.329x | +40.74% |
| 2019-12-31 | €2.90 Billion ≈ $3.39 Billion |
€677.90 Million ≈ $792.54 Million |
0.234x | +17.07% |
| 2018-12-31 | €2.72 Billion ≈ $3.18 Billion |
€543.90 Million ≈ $635.88 Million |
0.200x | +22.41% |
| 2017-12-31 | €2.48 Billion ≈ $2.90 Billion |
€405.12 Million ≈ $473.63 Million |
0.163x | -22.89% |
| 2016-12-31 | €1.76 Billion ≈ $2.05 Billion |
€371.84 Million ≈ $434.72 Million |
0.212x | -- |
About Eurofins Scientific SE
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection,… Read more